Box 1 summarizes the mutant APP or APP/PS‐overexpressing mouse models, including prospective ideas that may be experimentally validated to better consolidate the APP overexpression paradigm with human AD clinical pathogenesis (Huang & Mucke, 2012; Saito et al, 2014; Palop & Mucke, 2016). Here, APP is linked to Alzheimer disease.